Household Healthcare Sector

Orgenesis

Market Cap: US$12.5m

A biotech company, focuses on cell and gene therapies worldwide.

BioRestorative Therapies

Market Cap: US$12.5m

Develops therapeutic products and medical therapies using cell and tissue protocols primarily involving adult stem cells.

Bolt Biotherapeutics

Market Cap: US$12.3m

A clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer.

CS Diagnostics

Market Cap: US$12.2m

Manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally.

Marker Therapeutics

Market Cap: US$12.2m

A clinical-stage immuno-oncology company, engages in the development and commercialization of novel T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.

MSP Recovery

Market Cap: US$12.2m

MSP Recovery, Inc., doing business as LifeWallet, operates as a healthcare recovery and data analytics company in the United States and Puerto Rico.

BLIS Technologies

Market Cap: NZ$20.5m

Develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity.

Cosmos Health

Market Cap: US$12.2m

Manufactures, develops, and trades branded nutraceutical products in Greece, the United States, Croatia, Bulgaria, Ireland, the Cayman Islands, the UAE, the United Kingdom, and Cyprus.

Inspira Technologies Oxy B.H.N

Market Cap: US$12.2m

A specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.

Induction Healthcare Group

Market Cap: UK£8.9m

Provides software to healthcare professionals in the United Kingdom.

Aytu BioPharma

Market Cap: US$12.1m

A pharmaceutical company, focuses on commercializing novel therapeutics drugs in the United States and internationally.

Meihua International Medical Technologies

Market Cap: US$12.1m

Meihua International Medical Technologies Co., Ltd.

Red White & Bloom Brands

Market Cap: CA$16.5m

Manufactures, processes, and distributes cannabis products and accessories in the United States and Canada.

HCW Biologics

Market Cap: US$11.9m

A clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States.

Rhythm Biosciences

Market Cap: AU$18.4m

A medical diagnostics company, provides blood tests for the detection of cancers in Australia.

Evaxion

Market Cap: US$11.9m

A clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines.

Welsis

Market Cap: US$11.8m

A development stage startup company, engages in the provision of online psychological help services.

BetterLife Pharma

Market Cap: US$11.8m

A biotechnology company, primarily focuses on developing compounds for the treatment of mental disorders in Canada.

Hemostemix

Market Cap: CA$16.0m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

Numinus Wellness

Market Cap: CA$16.1m

Provides psychedelic-assisted psychotherapy products and services in Canada and the United States.

Aesthetic Medical International Holdings Group

Market Cap: US$11.6m

Provides aesthetic medical services in the People’s Republic of China and Singapore.

ImExHS

Market Cap: AU$18.0m

Offers cloud-based medical imaging solutions in Australia and internationally.

Sirona Biochem

Market Cap: CA$15.8m

A cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France.

Scienture Holdings

Market Cap: US$11.5m

Operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States.

Cellectar Biosciences

Market Cap: US$11.5m

A clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer in the United States.

BriaCell Therapeutics

Market Cap: CA$15.7m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

Hoth Therapeutics

Market Cap: US$11.2m

A clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs.

Bionano Genomics

Market Cap: US$11.2m

Provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.

COSCIENS Biopharma

Market Cap: CA$15.4m

A life science company, engages in developing and commercializing products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Columbia, the United Kingdom, and internationally.

genedrive

Market Cap: UK£8.2m

Engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications.

Guided Therapeutics

Market Cap: US$11.0m

A medical technology company, develops medical devices.

Aspire Biopharma Holdings

Market Cap: US$11.0m

An early-stage biopharmaceutical company, engages in development and marketing of disruptive technology for novel sublingual delivery mechanisms in the United States.

SeaStar Medical Holding

Market Cap: US$11.0m

A commercial-stage medical device company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States.

LexaGene Holdings

Market Cap: CA$14.8m

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.

SOL Global Investments

Market Cap: CA$15.0m

A private equity firm specializing in growth capital to small and mid-sized businesses.

STRATA Skin Sciences

Market Cap: US$10.8m

A medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, China, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.